Ephrin type-A receptor 2 (EPHA2)

Homo sapiens — UniProt P29317

Gene: EPHA2Homo sapiensSwissProt reviewed

About Ephrin type-A receptor 2

Ephrin type-A receptor 2 (EPHA2) is a protein from Homo sapiens identified by UniProt accession P29317, 976 residues long. MolForge cross-references it against 0 known binders and 526 disease associations.

Target properties

Protein nameEphrin type-A receptor 2
UniProt accessionP29317
GeneEPHA2
OrganismHomo sapiens
Length976 residues
Molecular weight—
EC numbers—
Target classUNCLASSIFIED
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Approved drugs hitting this target (14)

DrugCentral-linked approved drugs that act on this protein.

Disease associations (526)

Diseases linked to this target (Open Targets).

  • Posterior polar cataract · score 0.76
  • Total congenital cataract · score 0.76
  • chronic myelogenous leukemia · score 0.59
  • early-onset non-syndromic cataract · score 0.56
  • neurodegenerative disease · score 0.56
  • acute lymphoblastic leukemia · score 0.55
  • neoplasm · score 0.55
  • metastatic colorectal cancer · score 0.54
  • colorectal cancer · score 0.51
  • colorectal neoplasm · score 0.50

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-P29317-F1alphafoldPREDICTED82.23—

Amino-acid sequence (976 residues)

MELQAARACF ALLWGCALAA AAAAQGKEVV LLDFAAAGGE LGWLTHPYGK GWDLMQNIMN DMPIYMYSVC NVMSGDQDNW LRTNWVYRGE AERIFIELKF TVRDCNSFPG GASSCKETFN LYYAESDLDY GTNFQKRLFT KIDTIAPDEI TVSSDFEARH VKLNVEERSV GPLTRKGFYL AFQDIGACVA LLSVRVYYKK CPELLQGLAH FPETIAGSDA PSLATVAGTC VDHAVVPPGG EEPRMHCAVD GEWLVPIGQC LCQAGYEKVE DACQACSPGF FKFEASESPC LECPEHTLPS PEGATSCECE EGFFRAPQDP ASMPCTRPPS APHYLTAVGM GAKVELRWTP PQDSGGREDI VYSVTCEQCW PESGECGPCE ASVRYSEPPH GLTRTSVTVS DLEPHMNYTF TVEARNGVSG LVTSRSFRTA SVSINQTEPP KVRLEGRSTT SLSVSWSIPP PQQSRVWKYE VTYRKKGDSN SYNVRRTEGF SVTLDDLAPD TTYLVQVQAL TQEGQGAGSK VHEFQTLSPE GSGNLAVIGG VAVGVVLLLV LAGVGFFIHR RRKNQRARQS PEDVYFSKSE QLKPLKTYVD PHTYEDPNQA VLKFTTEIHP SCVTRQKVIG AGEFGEVYKG MLKTSSGKKE VPVAIKTLKA GYTEKQRVDF LGEAGIMGQF SHHNIIRLEG VISKYKPMMI ITEYMENGAL DKFLREKDGE FSVLQLVGML RGIAAGMKYL ANMNYVHRDL AARNILVNSN LVCKVSDFGL SRVLEDDPEA TYTTSGGKIP IRWTAPEAIS YRKFTSASDV WSFGIVMWEV MTYGERPYWE LSNHEVMKAI NDGFRLPTPM DCPSAIYQLM MQCWQQERAR RPKFADIVSI LDKLIRAPDS LKTLADFDPR VSIRLPSTSG SEGVPFRTVS EWLESIKMQQ YTEHFMAAGY TAIEKVVQMT NDDIKRIGVR LPGHQKRIAY SLLGLKDQVN TVGIPI

Explore Ephrin type-A receptor 2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtP29317
GeneEPHA2
OrganismHomo sapiens
Length976
Binders0
Diseases526
View on UniProt